CD20+CD3+ cells isolated from both HD and MS patients are a heterogeneous T cell population exhibiting predominantly central and effector memory (TEM) phenotypes, with enhanced activation and production of proinflammatory cytokines [6,7]. This evidence concerns the gene MS4A1 and myeloid sarcoma.